PLUR Pluri Inc

Price (delayed)

$5.6

Market cap

$30.18M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.13

Enterprise value

$52.91M

Pluristem Therapeutics Inc. is a leading regenerative medicine company developing novel placenta-based cell therapy product candidates. The Company has reported robust clinical trial data in multiple indications for its patented ...

Highlights
Pluri's EPS has increased by 43% YoY and by 11% QoQ
The net income is up by 30% year-on-year and by 10% since the previous quarter
Pluri's revenue has soared by 94% YoY but it has decreased by 4.5% from the previous quarter
The gross profit has soared by 89% YoY but it has contracted by 4.6% from the previous quarter
The equity has plunged by 108% from the previous quarter and by 102% YoY
The quick ratio has contracted by 30% YoY and by 15% from the previous quarter

Key stats

What are the main financial stats of PLUR
Market
Shares outstanding
5.39M
Market cap
$30.18M
Enterprise value
$52.91M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
85.74
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
155.15
Earnings
Revenue
$341,000
EBIT
-$19.95M
EBITDA
-$19.68M
Free cash flow
-$17.02M
Per share
EPS
-$4.13
Free cash flow per share
-$3.26
Book value per share
-$0.07
Revenue per share
$0.07
TBVPS
$6.97
Balance sheet
Total assets
$36.39M
Total liabilities
$34.55M
Debt
$30.08M
Equity
-$356,000
Working capital
$22.84M
Liquidity
Debt to equity
-84.5
Current ratio
6.05
Quick ratio
5.81
Net debt/EBITDA
-1.15
Margins
EBITDA margin
-5,772.1%
Gross margin
97.4%
Net margin
-6,339.6%
Operating margin
-6,647.5%
Efficiency
Return on assets
-49.9%
Return on equity
-328.8%
Return on invested capital
-32%
Return on capital employed
-62.6%
Return on sales
-5,851%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PLUR stock price

How has the Pluri stock price performed over time
Intraday
0.9%
1 week
4.67%
1 month
12.68%
1 year
600%
YTD
867.02%
QTD
-3.11%

Financial performance

How have Pluri's revenue and profit performed over time
Revenue
$341,000
Gross profit
$332,000
Operating income
-$22.67M
Net income
-$21.62M
Gross margin
97.4%
Net margin
-6,339.6%
Pluri's revenue has soared by 94% YoY but it has decreased by 4.5% from the previous quarter
The gross profit has soared by 89% YoY but it has contracted by 4.6% from the previous quarter
PLUR's net margin has surged by 64% year-on-year and by 5% since the previous quarter
Pluri's operating margin has surged by 60% YoY and by 2.1% QoQ

Growth

What is Pluri's growth rate over time

Valuation

What is Pluri stock price valuation
P/E
N/A
P/B
N/A
P/S
85.74
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
155.15
Pluri's EPS has increased by 43% YoY and by 11% QoQ
The equity has plunged by 108% from the previous quarter and by 102% YoY
Pluri's revenue has soared by 94% YoY but it has decreased by 4.5% from the previous quarter
PLUR's P/S is 6% below its last 4 quarters average of 91.5

Efficiency

How efficient is Pluri business performance
Pluri's return on equity has shrunk by 157% YoY and by 57% QoQ
Pluri's return on sales has surged by 67% YoY and by 6% QoQ
PLUR's return on invested capital is up by 22% year-on-year and by 2.4% since the previous quarter

Dividends

What is PLUR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PLUR.

Financial health

How did Pluri financials performed over time
The company's total assets is 5% higher than its total liabilities
The company's total assets fell by 35% YoY and by 12% QoQ
The current ratio has declined by 30% year-on-year and by 15% since the previous quarter
The equity has plunged by 108% from the previous quarter and by 102% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.